April 9 (Reuters) - A KKR-Stonepeak consortium would buy

British healthcare REIT Assura for 1.61 billion pounds

($2.06 billion), the companies said on Wednesday.

The deal comes shortly after Assura said it had rejected a

1.5 billion pound cash-and-stock takeover proposal from industry

peer Primary Health Properties ( PHPRF ), saying it was not at a

level that is sufficient to be recommended to shareholders.

Under the terms of the deal, shareholders will get 48.56

pence in cash for each share held and a quarterly interim

dividend of 0.84 pence.

The 49.4 pence-per-share bid was the fifth for Assura from

the consortium involving private equity giant KKR, and is at a

33.5% premium to Assura's closing price on February 13, a day

before the first bid was disclosed.

($1 = 0.7799 pounds)

(Reporting by Aby Jose Koilparambil, Raechel Thankam Job and

Chandini Monnappa in Bengaluru; Editing by Nivedita

Bhattacharjee and Mrigank Dhaniwala)